Skip to content
healthcare.dev

VEOPOZ

NDC 61755-014, Pozelimab, injection, solution, from Regeneron Pharmaceuticals, Inc..

Product NDC
61755-014
Status
Listed
Labeler
Regeneron Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761339
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61755-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POZELIMAB200 mg/mL

Pharmacologic classes

Complement Inhibitor [EPC]; Complement Inhibitors [MoA]

Package NDCNDC-11Package
61755-014-01617550014011 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a8d6f10e-9430-450a-a3dd-b538f9b2a308

Use it

Look up 61755-014 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61755-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61755-014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.